Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Antibodies
-
anti-NS3 (HCV), mAb (1B6)
AG-20B-0001 AG-20B-0001-TRIAL 25 µg CHF 150.00AG-20B-0001-C100 100 µg CHF 400.00 -
anti-NS5B (HCV), mAb (blocking) (5B-12B7)
AG-20B-0003 AG-20B-0003-TRIAL 25 µg CHF 150.00AG-20B-0003-C100 100 µg CHF 400.00 -
-
-
-
-
anti-Paxillin (human), Rabbit Monoclonal (RM256)
REV-31-1137-00 REV-31-1137-00-R100 100 µl CHF 477.00
-
anti-Periostin, mAb (blocking) (OC-20) (preservative free)
AG-20B-6000YPF AG-20B-6000YPF-C100 100 µg CHF 480.00AG-20B-6000YPF-C500 500 µg CHF 1’910.00Replaces AG-20B-6000PF
-
anti-Phospho-Histone H2A/H4 (Ser1), Rabbit Monoclonal (RM216)
REV-31-1092-00 REV-31-1092-00-C025 25 µg CHF 261.00REV-31-1092-00-C100 100 µg CHF 581.00
![Immunofluorescence using anti-PARP-10 [ARTD10] (human), mAb (5H11). <b>Method:</b> T47D mammary carcinoma cells were stained by indirect immunofluorescence and analysed. Prior to fixation and staining, the cells were treated with or without 50nm leptomyci](https://adipogen.com/media/catalog/product/cache/be9249d907792254897dc476f14d8e2a/a/g/ag-20t-0004-if.png)